Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced ...

Evolus said the Food and Drug Administration approved its injectable hyaluronic acid gels, known as Evolysse Form and Evolysse Smooth, in line with management expectations.

Sustainability and Innovation in Medical Grade Hyaluronic Acid Market: Trends and Opportunities (2025-2034)IntroductionThe ...

When it comes to non-surgical facial rejuvenation, two of the most popular treatments are Botox and hyaluronic acid (HA) fillers. While both are effective, they serve different purposes and are used ...

Evolus (EOLS) announced that the Food and Drug Administration has approved Evolysse Form and Evolysse Smooth injectable hyaluronic acid gels, ...

When a lip product is developed by a dermatologist, we take note. When a lip product promises to boost lip volume by up to 20 ...

By Christy Santhosh (Reuters) -Evolus said on Thursday the U.S. drug regulator has approved its two new anti-wrinkle gels, expanding the company's product portfolio beyond its cosmetic injection ...

CollPlant Biotechnologies (NASDAQ: CLGN), or 'CollPlant', a regenerative and aesthetics medicine company developing ...

CollPlant (CLGN) announced it has been granted U.S. Patent No. 12,186,449 related to its photocurable dermal filler product candidate. The ...

Plastic surgery has come a long way from its early days of rudimentary facelifts and basic reconstructions. Today, you can Transform Your Look with Rhinoplasty in Newport or even opt for breast ...

Radiesse and Restylane Lyft are the only two fillers that are FDA-approved for use in the hands, says Dr. Fabi, adding that ...

REHOVOT, Israel - CollPlant Biotechnologies (NASDAQ: CLGN), currently valued at $40.7 million in market capitalization, ...